Anti-phospho-Akt, pan, (Ser473) (PKB, RAC)

Anti-phospho-Akt, pan, (Ser473) (PKB, RAC)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
A1124-02V.100 100 µg - -

9 - 20 Werktage*

627,00 €
 
AKT, also known as protein kinase B (PKB), is a 57kD serine/threonine protein kinase. There are... mehr
Produktinformationen "Anti-phospho-Akt, pan, (Ser473) (PKB, RAC)"
AKT, also known as protein kinase B (PKB), is a 57kD serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold, overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus. AKT has two main roles: (i) inhibition of apoptosis, (ii) promotion of proliferation. AKT has been shown to play a role in such metabolic processes as glucose transport, glycogen synthesis, glycolysis, and protein synthesis. It had also been shown to promote cell survival by inhibiting apoptosis through its ability to phosphoylate and inactivate several targets, including Bad, Forkhead transcription factors, and caspase 9. Activity of AKT has been associated with the phosphorylation of two sites: T308, in the activation loop of the kinase, and S473, at the carboxyl terminus. Phosphorylation of both sites contributes to AKT activity, however phosphorylation of T308 has been shown to be absolutely essential for AKT activation. Applications: Suitable for use in ELISA, Western Blot and Immunoprecipitation. Other applications not tested. Recommended Dilution: ELISA: 0.25ug/ml Western Blot: 1ug/ml, Immunoprecipitation: 10ug/2mg, Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Schlagworte: EC=2.7.11.1, Anti-phospho-Akt1, Anti-phospho-PKB alpha, Anti-phospho-AKT1 kinase, Anti-phospho-RAC-PK-alpha, Anti-phospho-Protein kinase B, Anti-phospho-Proto-oncogene c-Akt, Anti-phospho-Protein kinase B alpha, Anti-phospho-Thymoma viral proto-oncogene
Hersteller: United States Biological
Hersteller-Nr: A1124-02V

Eigenschaften

Anwendung: ELISA, IP, WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: Synthetic peptide corresponding to human AKT (KLH).
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-phospho-Akt, pan, (Ser473) (PKB, RAC)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen